On November 5, Astrazeneca stated in a declaration that, as per company policy, it will not comment on speculative media reports at this time - including those related to the ongoing investigation in China. If needed, the company will fully cooperate with the Chinese law enforcement authorities. Astrazeneca will continue to provide drugs to Chinese patients, and its business operations are ongoing.
阿斯利康:暂不就正在进行中的调查置评,如有要求将全力配合中国执法部门
Astrazeneca: Currently, we do not comment on the ongoing investigation, but will fully cooperate with the Chinese law enforcement authorities if requested.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.